Abstract
Introduction: Surgical site infections (SSIs) remain a global challenge, affecting 14–16% of hospitalized patients. They can arise from endogenous skin flora or exogenous sources among high-risk patients (e.g., diabetes, anaemia, malnutrition and smoking). This study explores SSI incidence, risk factors, and microbiological profiles in emergency abdominal surgeries at Dr. RPGMC Tanda in North India.
Material and method: A retrospective analysis was conducted between April 2023 and March 2024 at Dr. RPGMC Kangra at Tanda. Patients undergoing emergency abdominal surgeries who developed postoperative wound infections within seven days were included, following strictly predefined inclusion and exclusion criteria. A proforma captured demographic and clinical details. Swabs were aseptically collected upon infection detection and again 72 hours later. Samples underwent direct microscopy, culture, biochemical testing, and antibiotic susceptibility assessment according to stringent standard laboratory procedures.
Results: Among 751 emergency surgical patients, 113 (15.04%) developed surgical site infections (SSIs). Males accounted for 58.4% of infections, whereas 41.6% involved females. Individuals older than 60 years recorded the highest incidence (33.3%). Of the 113 patients with SSIs, 37 (32.7%) presented no comorbidities. However, most patients exhibited one or more risk factors, particularly anemia (57%) and diabetes mellitus (55.4%), followed by smoking (28%), hypertension (10.6%), and COPD (1.8%). These findings underscore the substantial SSI burden and the significance of comorbidities in elevating infection risk, reinforcing the necessity for targeted preventive strategies and vigilant postoperative care. Robust prophylactic interventions remain warranted.
Discussion: Postoperative wound infections remain a significant concern after emergency abdominal surgeries. In this study, 15.4% developed SSIs, aligning with previous findings. Males were more affected (58.4%) than females (41.6%). Anaemia (57%) and diabetes (55.4%) dominated comorbidities, underscoring meticulous risk evaluation, glycaemic control, and early intervention for optimal outcomes and care.